View in EDS HTML Full Text PDF Full Text

Molecular tumor board in patients with metastatic breast cancer.

Saved in:
Bibliographic Details
Title: Molecular tumor board in patients with metastatic breast cancer.
Authors: Boscolo Bielo L; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Guerini Rocco E; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Crimini E; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Repetto M; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Lombardi M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Zanzottera C; Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141, Milan, Italy., Aurilio G; Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141, Milan, Italy., Barberis M; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Belli C; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Zhan Y; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy., Battaiotto E; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Katrini J; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Marsicano R; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Zagami P; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Taurelli Salimbeni B; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Esposito A; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Trapani D; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Criscitiello C; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy., Fusco N; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy., Marra A; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy., Curigliano G; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy. giuseppe.curigliano@ieo.it.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy. giuseppe.curigliano@ieo.it.
Source: Breast cancer research and treatment [Breast Cancer Res Treat] 2025 Feb; Vol. 210 (1), pp. 45-55. Date of Electronic Publication: 2024 Oct 30.
Publication Type: Evaluation Study; Journal Article
Journal Info: Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39476312
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Molecular tumor board in patients with metastatic breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Boscolo+Bielo+L%22">Boscolo Bielo L</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Guerini+Rocco+E%22">Guerini Rocco E</searchLink>; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Crimini+E%22">Crimini E</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Repetto+M%22">Repetto M</searchLink>; Early Drug Development Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Lombardi+M%22">Lombardi M</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zanzottera+C%22">Zanzottera C</searchLink>; Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Aurilio+G%22">Aurilio G</searchLink>; Division of Cancer Prevention and Genetics, European Institute of Oncology (IEO) IRCCS, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Barberis+M%22">Barberis M</searchLink>; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Belli+C%22">Belli C</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zhan+Y%22">Zhan Y</searchLink>; Department of Experimental Oncology, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Battaiotto+E%22">Battaiotto E</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Katrini+J%22">Katrini J</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Marsicano+R%22">Marsicano R</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zagami+P%22">Zagami P</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Taurelli+Salimbeni+B%22">Taurelli Salimbeni B</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Esposito+A%22">Esposito A</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Trapani+D%22">Trapani D</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Criscitiello+C%22">Criscitiello C</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Fusco+N%22">Fusco N</searchLink>; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.; Division of Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Marra+A%22">Marra A</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141, Milan, Italy. giuseppe.curigliano@ieo.it.; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy. giuseppe.curigliano@ieo.it.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228111104%22">Breast cancer research and treatment</searchLink> [Breast Cancer Res Treat] 2025 Feb; Vol. 210 (1), pp. 45-55. <i>Date of Electronic Publication: </i>2024 Oct 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Evaluation Study; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic%22">Kluwer Academic </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8111104 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7217 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201676806%22">01676806 </searchLink><i>NLM ISO Abbreviation: </i>Breast Cancer Res Treat <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39476312
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s10549-024-07535-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 45
    Titles:
      – TitleFull: Molecular tumor board in patients with metastatic breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Boscolo Bielo L
      – PersonEntity:
          Name:
            NameFull: Guerini Rocco E
      – PersonEntity:
          Name:
            NameFull: Crimini E
      – PersonEntity:
          Name:
            NameFull: Repetto M
      – PersonEntity:
          Name:
            NameFull: Lombardi M
      – PersonEntity:
          Name:
            NameFull: Zanzottera C
      – PersonEntity:
          Name:
            NameFull: Aurilio G
      – PersonEntity:
          Name:
            NameFull: Barberis M
      – PersonEntity:
          Name:
            NameFull: Belli C
      – PersonEntity:
          Name:
            NameFull: Zhan Y
      – PersonEntity:
          Name:
            NameFull: Battaiotto E
      – PersonEntity:
          Name:
            NameFull: Katrini J
      – PersonEntity:
          Name:
            NameFull: Marsicano R
      – PersonEntity:
          Name:
            NameFull: Zagami P
      – PersonEntity:
          Name:
            NameFull: Taurelli Salimbeni B
      – PersonEntity:
          Name:
            NameFull: Esposito A
      – PersonEntity:
          Name:
            NameFull: Trapani D
      – PersonEntity:
          Name:
            NameFull: Criscitiello C
      – PersonEntity:
          Name:
            NameFull: Fusco N
      – PersonEntity:
          Name:
            NameFull: Marra A
      – PersonEntity:
          Name:
            NameFull: Curigliano G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2025 Feb
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7217
          Numbering:
            – Type: volume
              Value: 210
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Breast cancer research and treatment
              Type: main
ResultId 1